Study Findings from University of Manchester Advance Knowledge in Rheumatoid Arthritis (Population Pharmacokinetic Analysis and Simulation of Alternative Dosing Regimens for Biosimilars to Adalimumab and Etanercept in Patients with Rheumatoid...).

MLA

“Study Findings from University of Manchester Advance Knowledge in Rheumatoid Arthritis (Population Pharmacokinetic Analysis and Simulation of Alternative Dosing Regimens for Biosimilars to Adalimumab and Etanercept in Patients with Rheumatoid...).” Immunotherapy Weekly, June 2024, p. 3291. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edo&AN=177710598&authtype=sso&custid=ns315887.

APA

Study Findings from University of Manchester Advance Knowledge in Rheumatoid Arthritis (Population Pharmacokinetic Analysis and Simulation of Alternative Dosing Regimens for Biosimilars to Adalimumab and Etanercept in Patients with Rheumatoid...). (2024). Immunotherapy Weekly, 3291.

Chicago

“Study Findings from University of Manchester Advance Knowledge in Rheumatoid Arthritis (Population Pharmacokinetic Analysis and Simulation of Alternative Dosing Regimens for Biosimilars to Adalimumab and Etanercept in Patients with Rheumatoid...).” 2024. Immunotherapy Weekly, June, 3291. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edo&AN=177710598&authtype=sso&custid=ns315887.